Literature DB >> 6332536

Marijuana use during pregnancy and decreased length of gestation.

P A Fried, B Watkinson, A Willan.   

Abstract

In a prospective study the relationship of marijuana use during pregnancy to infant birth weight and length of gestation was examined in 583 women who delivered single live infants. Eighty-four women used marijuana to varying degrees during pregnancy. Marijuana, alcohol, smoking, and nutritional habits were estimated by repeated interviews. Compared to nonuse, an average use of marijuana six or more times per week during pregnancy was associated with a statistically significant reduction of 0.8 weeks in the length of gestation after consideration of the effects of nicotine, alcohol, parity, mother's prepregnancy weight, and the sex of the infant. With similar adjustments no reduction in birth weight was noted. Among the heavy marijuana users the effect of gestation length was does dependent.

Entities:  

Mesh:

Year:  1984        PMID: 6332536     DOI: 10.1016/s0002-9378(84)80103-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.

Authors:  Catherine Lombard; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-08-10       Impact factor: 4.030

2.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Beliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report use.

Authors:  Judy C Chang; Jill A Tarr; Cynthia L Holland; Natacha M De Genna; Gale A Richardson; Keri L Rodriguez; Jeanelle Sheeder; Kevin L Kraemer; Nancy L Day; Doris Rubio; Marian Jarlenski; Robert M Arnold
Journal:  Drug Alcohol Depend       Date:  2019-01-11       Impact factor: 4.492

Review 5.  CB2 receptors in reproduction.

Authors:  M Maccarrone
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

6.  Maternal marijuana use and neonatal outcome: uncertainty posed by self-reports.

Authors:  R Hingson; B Zuckerman; H Amaro; D A Frank; H Kayne; J R Sorenson; J Mitchell; S Parker; S Morelock; R Timperi
Journal:  Am J Public Health       Date:  1986-06       Impact factor: 9.308

Review 7.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 8.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

9.  Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.

Authors:  Paul J Brighton; John McDonald; Anthony H Taylor; R A John Challiss; David G Lambert; Justin C Konje; Jonathon M Willets
Journal:  Mol Endocrinol       Date:  2009-05-28

10.  Effect of Ruta graveolens and Cannabis sativa alcoholic extract on spermatogenesis in the adult wistar male rats.

Authors:  M R Sailani; H Moeini
Journal:  Indian J Urol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.